Browse Category

Mergers & Acquisitions News 5 November 2025 - 8 November 2025

Pfizer (PFE) Clinches $10B Metsera Deal, Beating Novo Nordisk — What the Winning Bid Means for the Obesity-Drug Race (Nov. 8, 2025)

Pfizer (PFE) Clinches $10 Billion Metsera Deal as Novo Nordisk Exits—What It Means for the Obesity Drug Race (Nov. 8, 2025)

Key takeaways What happened (Nov. 7–8) Late Friday, Metsera accepted a sweetened offer from Pfizer: $65.60 per share in cash plus a contingent value right (CVR) of up to $20.65 per share, valuing the biotech at up to $10 billion. On Saturday, Novo Nordisk said it would not increase its bid and exited the race, citing legal and regulatory risks…
Pfizer (PFE) Clinches $10B Metsera Deal, Beating Novo Nordisk — What the Winning Bid Means for the Obesity-Drug Race (Nov. 8, 2025)

Pfizer (PFE) Clinches $10B Metsera Deal, Beating Novo Nordisk — What the Winning Bid Means for the Obesity-Drug Race (Nov. 8, 2025)

Pfizer Inc. (NYSE: PFE) has secured a definitive agreement to acquire weight‑loss biotech Metsera in a transaction valued at up to $10 billion, ending a high‑stakes bidding war with Novo Nordisk and positioning Pfizer squarely back in the fast‑growing obesity market. Metsera accepted Pfizer’s revised offer late Friday; Novo said today it would not raise its competing bid. Reuters Key…
Metsera (NASDAQ: MTSR): Pfizer Clinches $10B Deal as Novo Nordisk Bows Out — What to Know Today (Nov. 8, 2025)

Metsera (NASDAQ: MTSR): Pfizer Clinches $10B Deal as Novo Nordisk Bows Out — What to Know Today (Nov. 8, 2025)

Pfizer sealed a deal to acquire Metsera for up to $10 billion, ending one of 2025’s fiercest pharma bidding wars and reshaping the obesity‑drug race. Below are the facts, context, and what’s next for MTSR shareholders and the GLP‑1 landscape. What happened today Pfizer won the contest for Metsera, agreeing to acquire the clinical‑stage obesity‑drug developer in a transaction valued…
Dow Dips as Fed Fears Slam Tech Stocks – Hot Economic Data Rattles Wall Street (Sept 25, 2025)

Comcast (CMCSA) Stock Today — Nov. 7, 2025: Sky–ITV Talks and a Potential WBD Bid Put M&A in Focus as Shares Hover Near $27

Published: November 7, 2025 Key takeaways Comcast stock price snapshot (Nov. 7, 2025) Comcast Corporation (NASDAQ: CMCSA) traded modestly lower today, holding near the $27 handle. As of 19:33 UTC (2:33 p.m. ET), the stock printed $27.28 after opening at $27.56, with volume around 20.9 million shares. Intraday, CMCSA ranged $27.02–$27.77, reflecting an active tape as investors reacted to fresh…
Marvell Technology Stock Soars on AI Boom: Latest Price, Hot News & 2025 Outlook

Marvell Technology (MRVL) Slides as SoftBank Takeover Buzz Fades — Stock News for November 7, 2025

Summary: Marvell Technology (NASDAQ: MRVL) traded lower on Friday after yesterday’s pop tied to reports that SoftBank explored a takeover earlier this year. Investors are now refocusing on fundamentals and the company’s next earnings catalyst in early December. MarketWatch MRVL stock today: price action at a glance As of 19:27 UTC on November 7, 2025, MRVL changed hands at $88.64,…
Sweetgreen (NYSE: SG) Cuts 2025 Outlook, Sells Spyce Robotics to Wonder for $186.4M After Weak Q3 — 11/7/2025

Sweetgreen (NYSE: SG) Cuts 2025 Outlook, Sells Spyce Robotics to Wonder for $186.4M After Weak Q3 — 11/7/2025

What happened Sweetgreen reported third‑quarter FY2025 revenue of $172.4 million, down 0.6% year over year. Same‑store sales fell 9.5%, driven by an 11.7% drop in traffic and product mix, partly offset by 2.2% of price increases. Digital remained a majority of sales (61.8%), with 35.3% coming through owned digital channels. Restaurant‑level profit margin compressed to 13.1% from 20.1% a year…
Archer Aviation (ACHR) Raises $650M, Moves to Buy Hawthorne Airport for $126M; Shares Slip After Q3 Update — Nov. 7, 2025

Archer Aviation (ACHR) Raises $650M, Moves to Buy Hawthorne Airport for $126M; Shares Slip After Q3 Update — Nov. 7, 2025

Archer Aviation Inc. (NYSE: ACHR) unveiled a multi‑pronged update tied to its third‑quarter results: a $650 million equity raise, a deal to acquire control of Los Angeles’ Hawthorne Airport for $126 million, fresh flight‑test milestones for its Midnight eVTOL, and the closing of its Lilium patent portfolio purchase. The stock traded around $8.88 mid‑day as investors digested the capital raise…
Brighthouse Financial (BHF) to Be Acquired by Aquarian Capital for $4.1B at $70/Share; Stock Jumps — Nov. 6, 2025

Brighthouse Financial (BHF) to Be Acquired by Aquarian Capital for $4.1B at $70/Share; Stock Jumps — Nov. 6, 2025

Brighthouse Financial, Inc. (NASDAQ: BHF) said this morning it has entered into a definitive agreement to be acquired by Aquarian Capital in an all‑cash deal valuing the company at approximately $4.1 billion, or $70.00 per share. The transaction would take the U.S. life insurer and annuity provider private and is expected to close in 2026, pending shareholder and regulatory approvals.…
Strive Asset Management (ASST) prices upsized 12% preferred stock IPO to raise ~$160M; fresh Semler (SMLR) merger filing lands — Nov. 6, 2025

Strive Asset Management (ASST) prices upsized 12% preferred stock IPO to raise ~$160M; fresh Semler (SMLR) merger filing lands — Nov. 6, 2025

Strive, Inc. (Nasdaq: ASST)—the parent of Strive Asset Management, LLC—priced an upsized initial public offering of its Variable Rate Series A Perpetual Preferred Stock (“SATA Stock”) at $80 per share, expanding the deal to 2,000,000 shares for ~$160 million in expected gross proceeds. Settlement is slated for Monday, November 10, 2025, pending customary closing conditions. The preferred carries an initial…
Comstock Resources (CRK) Jumps as Q3 Results, $430M Divestiture and Rising RS Rating Put Haynesville Gas in Focus — Nov. 6, 2025

Comstock Resources (CRK) Jumps as Q3 Results, $430M Divestiture and Rising RS Rating Put Haynesville Gas in Focus — Nov. 6, 2025

FRISCO, Texas — Nov. 6, 2025. Shares of Comstock Resources, Inc. (NYSE: CRK) traded higher today after a week packed with catalysts: stronger third‑quarter results, progress on a $430 million asset sale, and a fresh technical tailwind as the stock’s Relative Strength (RS) rating ticked up. Midday, CRK changed hands around $21.14, up roughly 5.5%, within a 52‑week range of…
Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook

Pfizer (PFE) today: Court denies bid to block Novo–Metsera deal; Pfizer preps sweeter offer and leans on higher 2025 EPS outlook

Key takeaways What happened today (Nov. 6) 1) Court clears the way for Metsera to pivot to Novo’s richer bid.On Wednesday evening, the Delaware Chancery Court denied Pfizer’s TRO request that sought to keep Metsera bound to its earlier merger agreement with Pfizer. In a same‑day statement, Pfizer argued the decision “does not address the merits” and vowed to pursue…
SNAP Stock Just Got a 48‑Hour Jolt: India Creator Boom, New Sticker Push—and a $14B TikTok Twist Investors Can’t Ignore

Snap (SNAP) earnings today — Nov. 5, 2025: Revenue up 10% to $1.51B; $400M Perplexity AI deal and $500M buyback lift sentiment

Published: November 5, 2025 At a glance (Q3 2025) What happened today Snap reported September‑quarter (Q3 2025) revenue of $1.507B, up 10% year over year, with net loss narrowing to $104M (–$0.06 per diluted share). Management also authorized a $500M repurchase program, funded from Snap’s $3.0B cash and marketable securities balance. Snap Inc. Investor Relations User engagement continued to expand:…
1 24 25 26 27 28 34

Stock Market Today

  • Salesforce stock hits seven-week low; investors watch Davos AI push
    January 18, 2026, 5:00 PM EST. Salesforce (CRM) closed Friday at $227.11, down about 2.8% and at its lowest close since Nov. 26, extending a four-session slide and dropping roughly 12% for the week, according to StockAnalysis and MarketWatch. U.S. markets will be closed Monday for MLK Day; trading resumes Tuesday. With no earnings update or guidance change, moves may be sentiment-driven. The company is pushing its Agentforce AI and an on-site concierge app, EVA, at the World Economic Forum in Davos (Jan. 19-23). SEC filings show director Neelie Kroes sold 3,893 shares near $238.70. Analysts, including Aptus Capital's David Wagner, warn AI monetization timing is uncertain and note a rotation into semiconductors.
Go toTop